Botanical Therapeutics for Parkinson's Disease

Area of Science:

• Neurology
• Pharmacology
• Integrative Medicine

Background:

• Parkinson's disease (PD) was first described in 1817, with historical mentions of limb shaking in ancient texts.
• Botanical drugs were historically primary treatments for PD, but synthetic dopaminergic (DA) medications now dominate.
• Current DA medications manage PD symptoms but have diminishing efficacy and adverse effects with long-term use, necessitating novel treatments.

Purpose of the Study:

• To explore the potential of traditional botanical drugs, specifically Chinese medicine (CM), as a viable treatment for Parkinson's disease.
• To review modern pharmacological evidence supporting the therapeutic effects of Chinese herbs on PD pathology.
• To assess the feasibility of integrating CM into mainstream PD treatment strategies.

Main Methods:

• Review of historical medical literature on PD treatments.
• Analysis of modern pharmacological studies on Chinese herbs and their mechanisms of action.
• Examination of CM's holistic approach and its application in neurodegenerative disorders.

Main Results:

• Modern studies confirm Chinese herbs possess therapeutic properties beneficial for PD.
• Identified mechanisms include enhancing neurotrophic activity, clearing protein aggregates, and regulating neuroinflammation.
• These findings support the potential of CM in managing PD.

Conclusions:

• Chinese medicine offers a promising alternative or complementary approach to conventional Parkinson's disease treatments.
• Botanical drugs derived from CM warrant further investigation for PD therapy development.
• Integrating CM could provide new hope for effective and safer long-term management of Parkinson's disease.